As a whole, these examples illustrate that oncogenic alterations in ERK1/2 signaling pathway, which has a crucial role in sustaining proliferative programs, determine a metabolic switch from mitochondrial metabolism to glycolysis in cancer cells, fulfilling the energetic and biosynthetic requirements for tumor growth. Here, MAPK3 is linked to cancer.